Table 2 Characteristics of the patients who exhibited an DR
No. | Gender | Age (years) | Histology (tumour type) | Time of DRAppears (weeks) | RECIST 1.1 | Response site | Progression site | ICIs treatment after DR (months) | Duration of ICIs treatment after DR (months) |
|---|---|---|---|---|---|---|---|---|---|
1 | F | 67 | Adenocarcinoma (lung) | 8 | SD | liver | lung | PD-1+RT | 13.5 |
2 | M | 76 | Adenocarcinoma (colorectum) | 21 | SD | liver | liver | None | / |
3 | M | 67 | Adenocarcinoma (lung) | 22 | SD | lung | lung, LN | None | / |
4 | F | 75 | Adenocarcinoma (lung) | 7 | SD | peritoneal cavity | colon | PD-1 | 15.7 |
5 | F | 58 | Sarcoma (retroperitoneum) | 23 | SD | peritoneal cavity | peritoneal cavity | PD-1 | 13.5 |
6 | F | 64 | Infiltrating ductal carcinoma (Breast) | 21 | PR | lung | lung | PD-1 | 26 |
7 | F | 65 | Leiomyosarcoma (Cervix) | 7 | SD | lung, rectum | lung | PD-1+RT | 11.5 |
8 | F | 53 | Papillar carcinoma (kidney) | 8 | SD | LN | LN | PD-1+RT | 11.9 |
9 | M | 68 | Squamous cell carcinoma (lung) | 15 | PD | LN | NL (lung) | PD-1+RT | 19.4 |
10 | F | 53 | Squamous cell carcinoma (lung) | 24 | PD | peritoneum, pleura | pleura | None | / |
11 | M | 62 | Squamous cell carcinoma (esophagus) | 12 | SD | lung | lung | None | / |
12 | M | 77 | Adenocarcinoma (colorectum) | 8 | PD | lung, liver | lung, liver | PD-1+RT | 3.4 |
13 | F | 52 | Adenocarcinoma (cervix) | 16 | SD | liver | LN | None | / |
14 | F | 76 | Adenocarcinoma (bile duct) | 12 | PD | liver | NL (liver) | None | / |
15 | M | 71 | Adenocarcinoma (prostate) | 38 | PD | lung | lung | None | / |
16 | F | 51 | Serous epithelial carcinoma (ovary) | 13 | SD | peritoneal cavity | Abdominal wall | None | / |
17 | F | 31 | Squamous cell carcinoma (cervix) | 8 | PD | LN | NL (lung) | None | / |
18 | M | 71 | Adenocarcinoma (colorectum) | 15 | PD | lung | LN | PD-1 | 7.2 |
19 | F | 66 | Adenocarcinoma (pancreas) | 6 | PD | peritoneal cavity | liver | None | / |
20 | F | 42 | Adenocarcinoma (liver) | 12 | SD | liver | LN | PD-1 | 28.2 |
21 | F | 43 | Squamous cell carcinoma (cervix) | 12 | PD | LN | LN | PD-1+RT | 24.5 |
22 | F | 37 | Adenocarcinoma (Head and neck) | 27 | PR | lung | lung | PD-1 | 15.3 |